Oxidative Stress Mechanisms in Diabetic Kidney Disease

Diabetic kidney disease arises from chronic hyperglycaemia that disrupts redox homeostasis and overwhelms endogenous antioxidant systems. Excess glucose metabolism through the mitochondrial electron transport chain and activation of NADPH oxidases generates reactive oxygen species (ROS), which in turn oxidise lipids, proteins and nucleic acids. Advanced glycation end-products (AGEs) and hyperactive protein kinase C further amplify ROS production and activate pro-inflammatory transcription factors such as NF-κB. Sustained oxidative stress provokes podocyte injury, mesangial expansion and tubular epithelial cell apoptosis, driving glomerulosclerosis and interstitial fibrosis. Counter-regulatory pathways, notably the Nrf2-mediated antioxidant response and AMPK-SIRT1 signalling, become impaired in diabetes, reducing expression of enzymes such as superoxide dismutase and heme oxygenase-1. The reciprocal interplay between oxidative stress and inflammation establishes a vicious cycle that accelerates renal damage. Understanding these interconnections has global significance, given that diabetic kidney disease is a leading cause of end-stage renal failure. Therapeutic strategies under investigation include NOX4 inhibitors, Nrf2 activators and lifestyle interventions enriched in dietary antioxidants, all aiming to restore redox balance, preserve glomerular filtration and prevent progression to dialysis.

Research from Nature Portfolio

Network pharmacology approaches have been applied to an herbal compound to uncover multi-target modulation of oxidative stress and inflammation in diabetic nephropathy. Key active ingredients were predicted to interact with proteins involved in apoptosis, redox regulation and cytokine signalling, including VEGFA, TP53, IL-6 and TNF. Molecular docking confirmed high-affinity binding to these targets. In diabetic rat models, administration of the compound reduced fasting glucose, enhanced insulin levels, improved renal function and lowered urinary protein excretion. Histological analyses showed attenuated glomerular basement membrane thickening and reduced extracellular matrix deposition. This integrative study highlights the potential of network-based drug discovery to identify new interventions that modulate oxidative stress networks in the diabetic kidney.

Oxidative Stress Mechanisms in Diabetic Kidney Disease publication trend

The graph below shows the total number of articles in oxidative stress mechanisms in diabetic kidney disease across all publications each year (not limited to Nature Index journals).

Technical terms

Reactive oxygen species (ROS): Highly reactive molecules derived from oxygen that can oxidise cellular macromolecules when not adequately neutralised.

NADPH oxidase (NOX): Membrane-associated enzyme complex that transfers electrons from NADPH to molecular oxygen, producing superoxide.

Advanced glycation end-products (AGEs): Irreversible adducts formed when reducing sugars react non-enzymatically with proteins or lipids, promoting oxidative stress and inflammation.

Nuclear factor erythroid 2-related factor 2 (Nrf2): Master transcription factor that binds antioxidant response elements to induce expression of cytoprotective genes.

Malondialdehyde (MDA): Lipid peroxidation product commonly measured as a biomarker of oxidative damage.

References

1. Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy. International Journal of Endocrinology (2018).
2. Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia. Cardiovascular Diabetology (2024).
3. Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols. Frontiers in Immunology (2023).
4. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy. Scientific Reports (2021).